Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2020, Vol. 14 Issue (4) : 498-505    https://doi.org/10.1007/s11684-020-0791-8
RESEARCH ARTICLE
Efficacy of intelligent diagnosis with a dynamic uncertain causality graph model for rare disorders of sex development
Dongping Ning1,2, Zhan Zhang3, Kun Qiu3, Lin Lu1(), Qin Zhang4(), Yan Zhu5, Renzhi Wang6
1. Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
2. Department of Pediatrics, Linfen Central Hospital, Linfen 041000, China
3. Institute of Nuclear and New Energy Technology, Tsinghua University, Beijing 100084, China
4. Department of Computer Science and Technology, Tsinghua University, Beijing 100084, China
5. Institute of Internet Industry, Tsinghua University, Beijing 100084, China
6. Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
 Download: PDF(2140 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Disorders of sex development (DSD) are a group of rare complex clinical syndromes with multiple etiologies. Distinguishing the various causes of DSD is quite difficult in clinical practice, even for senior general physicians because of the similar and atypical clinical manifestations of these conditions. In addition, DSD are difficult to diagnose because most primary doctors receive insufficient training for DSD. Delayed diagnoses and misdiagnoses are common for patients with DSD and lead to poor treatment and prognoses. On the basis of the principles and algorithms of dynamic uncertain causality graph (DUCG), a diagnosis model for DSD was jointly constructed by experts on DSD and engineers of artificial intelligence. “Chaining” inference algorithm and weighted logic operation mechanism were applied to guarantee the accuracy and efficiency of diagnostic reasoning under incomplete situations and uncertain information. Verification was performed using 153 selected clinical cases involving nine common DSD-related diseases and three causes other than DSD as the differential diagnosis. The model had an accuracy of 94.1%, which was significantly higher than that of interns and third-year residents. In conclusion, the DUCG model has broad application prospects as a computer-aided diagnostic tool for DSD-related diseases.

Keywords disorders of sex development (DSD)      intelligent diagnosis      dynamic uncertain causality graph     
Corresponding Author(s): Lin Lu,Qin Zhang   
Just Accepted Date: 19 May 2020   Online First Date: 20 July 2020    Issue Date: 26 August 2020
 Cite this article:   
Dongping Ning,Zhan Zhang,Kun Qiu, et al. Efficacy of intelligent diagnosis with a dynamic uncertain causality graph model for rare disorders of sex development[J]. Front. Med., 2020, 14(4): 498-505.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-020-0791-8
https://academic.hep.com.cn/fmd/EN/Y2020/V14/I4/498
Fig.1  Subgraph of the 21OHD model in the DUCG.
Fig.2  Subgraph of the PCOS model in the DUCG.
Fig.3  DUCG with DSDs as the chief complaint combined with 12 subgraphs, two of which are illustrated in Figs. 1 and 2.
Recruited DSD patients Number of ?cases Diagnostic ?accuracy ?of the DUCG ?model Diagnostic ?accuracy ?of interns Diagnostic ?accuracy ?of third-year ?residents P value
21-Alpha hydroxylase deficiency (21OHD) 23 100% 82.6% 86.9% 0.127
11β-Hydroxylase deficiency (11βOHD) 10 90% 70% 70% 0.475
17-Hydroxylase deficiency (17OHD) 20 90% 75% 85% 0.432
Steroidogenic acute regulatory (StAR) protein mutations 11 100% 72.7% 81.8% 0.192
3β-Hydroxysteroid dehydrogenase deficiency (3βHSD) 9 88.9% 55.6% 55.6% 0.223
P450 oxidoreductase deficiency (PORD) 3 100% 0% 66.7% NA
Androgen insensitivity syndrome (AIS) 13 84.6% 53.8% 76.9% 0.293
5α-Reductase deficiency 10 90% 40% 70% 0.080
17β-Hydroxysteroid dehydrogenase deficiency (17βHSD)* 13 100% 53.8% 61.5% 0.019
Androgen-producing tumor 19 89.4% 68.4% 73.7% 0.376
Polycystic ovary syndrome (PCOS)* 12 100% 58.3% 83.3% 0.046
Hypercortisolism 10 100% 70% 90% 0.286
Total* (all the above DSD cases) 153 94.1% 64.7% 77.1% <0.001
Tab.1  Accuracy of the DUCG diagnostic model for patients with DSDs and non-DSD-related diseases
1 M Cools, A Nordenström, R Robeva, J Hall, P Westerveld, C Flück, B Köhler, M Berra, A Springer, K Schweizer, V Pasterski; COST Action BM1303 working group 1. Caring for individuals with a difference of sex development (DSD): a Consensus Statement. Nat Rev Endocrinol 2018; 14(7): 415–429
https://doi.org/10.1038/s41574-018-0010-8 pmid: 29769693
2 PA Lee, CP Houk, SF Ahmed, IA Hughes; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. Pediatrics 2006; 118(2): e488–e500
https://doi.org/10.1542/peds.2006-0738 pmid: 16882788
3 M Ono, VR Harley. Disorders of sex development: new genes, new concepts. Nat Rev Endocrinol 2013; 9(2): 79–91
https://doi.org/10.1038/nrendo.2012.235 pmid: 23296159
4 AL Boehmer, O Brinkmann, H Brüggenwirth, C van Assendelft, BJ Otten, MC Verleun-Mooijman, MF Niermeijer, HG Brunner, CW Rouwé, JJ Waelkens, W Oostdijk, WJ Kleijer, TH van der Kwast, MA de Vroede, SL Drop. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 2001; 86(9): 4151–4160
https://doi.org/10.1210/jcem.86.9.7825 pmid: 11549642
5 HH Lee, JM Kuo, HT Chao, YJ Lee, JG Chang, CH Tsai, BC Chung. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese. J Clin Endocrinol Metab 2000; 85(2): 597–600
https://doi.org/10.1210/jc.85.2.597 pmid: 10690861
6 AY Rawal, PF Austin. Concepts and updates in the evaluation and diagnosis of common disorders of sexual development. Curr Urol Rep 2015; 16(12): 83
https://doi.org/10.1007/s11934-015-0556-0 pmid: 26547422
7 D El-Maouche, W Arlt, DP Merke. Congenital adrenal hyperplasia. Lancet 2017; 390(10108): 2194–2210
https://doi.org/10.1016/S0140-6736(17)31431-9 pmid: 28576284
8 H Ostrer. Disorders of sex development (DSDs): an update. J Clin Endocrinol Metab 2014; 99(5): 1503–1509
https://doi.org/10.1210/jc.2013-3690 pmid: 24758178
9 J Kremen, YM Chan. Genetic evaluation of disorders of sex development: current practice and novel gene discovery. Curr Opin Endocrinol Diabetes Obes 2019; 26(1): 54–59
https://doi.org/10.1097/MED.0000000000000452 pmid: 30507699
10 L Audi, SF Ahmed, N Krone, M Cools, K McElreavey, PM Holterhus, A Greenfield, A Bashamboo, O Hiort, SA Wudy, R McGowan; The EU COST Action. GENETICS IN ENDOCRINOLOGY: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’. Eur J Endocrinol 2018; 179(4): R197–R206
https://doi.org/10.1530/EJE-18-0256 pmid: 30299888
11 G Hyun, TF Kolon. A practical approach to intersex in the newborn period. Urol Clin North Am 2004; 31(3): 435–443
https://doi.org/10.1016/j.ucl.2004.04.008 pmid: 15313053
12 EA Eugster, LA Dimeglio, JC Wright, GR Freidenberg, R Seshadri, OH Pescovitz. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 2001; 138(1): 26–32
https://doi.org/10.1067/mpd.2001.110527 pmid: 11148508
13 K Muthusamy, MB Elamin, G Smushkin, MH Murad, JF Lampropulos, KB Elamin, NO Abu Elnour, JF Gallegos-Orozco, MM Fatourechi, N Agrwal, MA Lane, FN Albuquerque, PJ Erwin, VM Montori. Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab 2010; 95(9): 4161–4172
https://doi.org/10.1210/jc.2009-2616 pmid: 20823467
14 C Dong, Y Wang, Q Zhang, N Wang. The methodology of dynamic uncertain causality graph for intelligent diagnosis of vertigo. Comput Methods Programs Biomed 2014; 113(1): 162–174
https://doi.org/10.1016/j.cmpb.2013.10.002 pmid: 24176413
15 PA Lee, A Nordenström, CP Houk, SF Ahmed, R Auchus, A Baratz, K Baratz Dalke, LM Liao, K Lin-Su, LH Looijenga 3rd, T Mazur, HFL Meyer-Bahlburg, P Mouriquand, CA Quigley, DE Sandberg, E Vilain, S Witchel; Global DSD Update Consortium. Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr 2016; 85(3): 158–180
https://doi.org/10.1159/000442975 pmid: 26820577
16 A Kulle, N Krone, PM Holterhus, G Schuler, RF Greaves, A Juul, YB de Rijke, MF Hartmann, A Saba, O Hiort, SA Wudy; EU COST Action. Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 ‘DSDnet’. Eur J Endocrinol 2017; 176(5): P1–P9
https://doi.org/10.1530/EJE-16-0953 pmid: 28188242
17 Q Zhang. Dynamic uncertain causality graph for knowledge representation and reasoning: discrete DAG cases. J Comput Sci Technol 2012; 27(1): 1–23
https://doi.org/10.1007/s11390-012-1202-7
18 Q Zhang, C Dong, Y Cui, Z Yang. Dynamic uncertain causality graph for knowledge representation and probabilistic reasoning: statistics base, matrix, and application. IEEE Trans Neural Netw Learn Syst 2014; 25(4): 645–663
https://doi.org/10.1109/TNNLS.2013.2279320 pmid: 24807944
19 SR Hao, SC Geng, LX Fan, JJ Chen, Q Zhang, LJ Li. Intelligent diagnosis of jaundice with dynamic uncertain causality graph model. J Zhejiang Univ Sci B 2017; 18(5): 393–401
https://doi.org/10.1631/jzus.B1600273 pmid: 28471111
20 XJ Bao, YH Fan, Z Zhang, ZQ Jing, Y Wang, ZY Liu, MJ Guo, RZ Wang, M Feng. Diagnostic value of dynamic uncertain causality graph in sellar region disease. Chin J Minim Invasive Neurosurg (Zhongguo Wei Qin Xi Shen Jing Wai Ke Za Zhi) 2018; 23(06): 249–253 (in Chinese)
21 S Chen, ZX Pan, HJ Zhu, Q Wang, JJ Yang, Y Lei, JQ Li, H Pan. Development of a computer-aided tool for the pattern recognition of facial features in diagnosing Turner syndrome: comparison of diagnostic accuracy with clinical workers. Sci Rep 2018; 8(1): 9317
https://doi.org/10.1038/s41598-018-27586-9 pmid: 29915349
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed